Drugs / Herpes Zoster Subunit (HZ/su) Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05559671 | Dec 2023 → Jul 2027 expected | systemic lupus erythematosus | NYU Langone Health | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Herpes Zoster Subunit (HZ/su) Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05559671 ↗ |
| Modality | Vaccine | “Herpes Zoster Subunit (HZ/su) Vaccine” NCT05559671 ↗ |